medtest bIOMEDICAL
沺盛實業股份有限公司

medtest bIOMEDICAL 沺盛實業股份有限公司medtest bIOMEDICAL 沺盛實業股份有限公司medtest bIOMEDICAL 沺盛實業股份有限公司

medtest bIOMEDICAL
沺盛實業股份有限公司

medtest bIOMEDICAL 沺盛實業股份有限公司medtest bIOMEDICAL 沺盛實業股份有限公司medtest bIOMEDICAL 沺盛實業股份有限公司
  • TW
  • EN
  • 更多
    • TW
    • EN
  • TW
  • EN

Let medical care be comfortable, Let life be dignified.

關於我們

The company's founder and co-founders established the company's purpose:

    Let medical care be comfortable,                     

    Let life dignified  

MEDTEST focuses on discovering innovative and highly accurate diagnostic solutions aimed at helping healthcare professionals and patients quickly and easily identify the cause of illness, reducing the waiting time and discomfort during the diagnosis and treatment process. Through continuous technological innovation, we are committed to improving healthcare efficiency, enhancing treatment outcomes, and providing patients with higher-quality medical care.


Our mission is to achieve faster and more accurate disease identification through advanced diagnostic tools, ensuring that every patient receives timely medical support. Let healthcare be more comfortable, and life more dignified. We are dedicated to providing the necessary tools for patients and healthcare professionals to achieve better treatment outcomes and rebuild confidence and hope throughout the recovery journey.

Authorized Brand:

Prognosis Biotech from Greece, committed to quality and Greek manufacturing.

Products

Prognosis Respiratory Syncytial Virus

Prognosis Respiratory Syncytial Virus

Prognosis Respiratory Syncytial Virus

  Respiratory Syncytial Virus (RSV) is a highly contagious respiratory virus that can cause severe illness, particularly in young children, the elderly, and individuals with weakened immune systems.

This virus is very common, with most children being infected by the age of two. In most cases, it causes mild, cold-like symptoms, but for a s

  Respiratory Syncytial Virus (RSV) is a highly contagious respiratory virus that can cause severe illness, particularly in young children, the elderly, and individuals with weakened immune systems.

This virus is very common, with most children being infected by the age of two. In most cases, it causes mild, cold-like symptoms, but for a small percentage of individuals, RSV infection can lead to severe and even life-threatening complications. Infants, young children, individuals with weakened immune systems, and older adults are at higher risk for severe disease.

The Prognosis Biotech Rapid Test RSV is an immunoassay kit that helps healthcare professionals detect RSV proteins and provides rapid diagnosis within minutes, making it an essential tool for quick diagnosis and timely treatment of the virus.

Prognosis Adenovirus

Prognosis Respiratory Syncytial Virus

Prognosis Respiratory Syncytial Virus

  Adenoviruses are common in humans, usually cause respiratory illness while also being responsible for gastroenteritis, conjunctivitis, cystitis.

Symptoms of respiratory illness range from the common cold syndrome to pneumonia, affect all ages and do not show seasonal infection. Most serious infections occur in individuals who are immunoc

  Adenoviruses are common in humans, usually cause respiratory illness while also being responsible for gastroenteritis, conjunctivitis, cystitis.

Symptoms of respiratory illness range from the common cold syndrome to pneumonia, affect all ages and do not show seasonal infection. Most serious infections occur in individuals who are immunocompromised and young children.

Prognosis Biotech Rapid Test Adenovirus is a qualitative immunoassay kit that helps laboratories and physicians detect the adenovirus antigen and confirm the diagnosis of adenovirus in patients with a respiratory illness.


 

Prognosis influenza A_B

Prognosis Respiratory Syncytial Virus

Prognosis influenza A_B

  Influenza A and B viruses are the primary causes of seasonal flu, resulting in millions of cases worldwide each year and potentially increasing hospitalizations among high-risk populations.

The Prognosis Biotech Influenza A/B Rapid Test is designed to detect whether a patient is infected with Influenza A or B viruses, aiding in the diagn

  Influenza A and B viruses are the primary causes of seasonal flu, resulting in millions of cases worldwide each year and potentially increasing hospitalizations among high-risk populations.

The Prognosis Biotech Influenza A/B Rapid Test is designed to detect whether a patient is infected with Influenza A or B viruses, aiding in the diagnosis of suspected flu cases. Symptoms of influenza include fever, cough, muscle aches, and fatigue.

This test works by detecting specific antigens (proteins) on the surface of the influenza virus.

Accurate detection and diagnosis of the flu within a few days of symptom onset is crucial for the timely initiation of treatment. The Prognosis Biotech Influenza A/B Rapid Test utilizes a novel, rapid immunoassay technology, providing fast and reliable results, enabling healthcare providers to confidently use it in clinical settings.

Streptococcus Group A (STREP-A)

Streptococcus Group A (STREP-A)

Streptococcus Group A (STREP-A)

  The Rapid Test Strep A is a fast, simple, and reliable diagnostic tool designed to quickly identify the presence of Group A Streptococcus (GAS) in throat swab samples within just 5 minutes. This test is crucial for the early detection and proper treatment of bacterial throat infections, most commonly known as strep throat.

Group A Strept

  The Rapid Test Strep A is a fast, simple, and reliable diagnostic tool designed to quickly identify the presence of Group A Streptococcus (GAS) in throat swab samples within just 5 minutes. This test is crucial for the early detection and proper treatment of bacterial throat infections, most commonly known as strep throat.

Group A Streptococcus (Strep A or GAS) is a type of bacteria that can cause a range of human infections, from mild illnesses such as strep throat and impetigo to more severe conditions like rheumatic fever and invasive infections. Strep throat, the most common manifestation of a Strep A infection, is characterized by a sore throat, fever, and swollen lymph nodes. Early detection and treatment of Strep A infections are vital to prevent complications and reduce the risk of spreading the bacteria to others. The Rapid Test Strep A plays a key role in enabling prompt diagnosis and effective treatment of these infections.

Rapid Test Ag 2019-nCoV

Streptococcus Group A (STREP-A)

Streptococcus Group A (STREP-A)

  The Rapid Test Ag 2019-nCov is a rapid diagnostic test designed to detect the presence of the novel coronavirus (SARS-CoV-2) in individuals suspected of infection. Prognosis Biotech has developed this rapid test kit to detect the SARS-CoV-2 antigen (nucleocapsid protein) in nasopharyngeal and nasal swab samples.

This test is designed to 

  The Rapid Test Ag 2019-nCov is a rapid diagnostic test designed to detect the presence of the novel coronavirus (SARS-CoV-2) in individuals suspected of infection. Prognosis Biotech has developed this rapid test kit to detect the SARS-CoV-2 antigen (nucleocapsid protein) in nasopharyngeal and nasal swab samples.

This test is designed to quickly identify infected individuals, facilitating rapid clinical decision-making and preventing potential viral outbreaks.

The Rapid Test Ag 2019-nCov is an important tool in the fight against COVID-19 as it enables quick and convenient testing of individuals who may have been exposed to the virus.

The Prognosis Biotech Rapid Test Ag 2019-nCov is non-invasive, requires no special instruments or skills, and can be used in any setting where COVID-19 testing is needed.

human Metapneumovirus, hMPV

Streptococcus Group A (STREP-A)

human Metapneumovirus, hMPV

  Infection can present a range of respiratory symptoms, from mild upper respiratory tract infections to severe lower respiratory tract infections, which may even lead to hospitalization and death. Mild infections are typically treated symptomatically, while severe cases require aggressive critical care, including oxygen therapy, respirat

  Infection can present a range of respiratory symptoms, from mild upper respiratory tract infections to severe lower respiratory tract infections, which may even lead to hospitalization and death. Mild infections are typically treated symptomatically, while severe cases require aggressive critical care, including oxygen therapy, respiratory support, and mechanical ventilation, among other interventions. Diagnosing hMPV (human metapneumovirus) infection can be challenging.


Rhinovirus Rapid Test Cassette

  Rhinovirus is the most common virus responsible for the common cold, followed by coronaviruses. It is a non-enveloped, positive-strand RNA virus, named for causing inflammation in the nose. Rhinovirus is a major pathogen causing respiratory infections in children, with symptoms generally being mild, including fever, runny nose, and headache.

Key characteristics of rhinovirus include:

  1. Year-round presence: It thrives in the nasal passages, and infections often result in symptoms such as excessive nasal discharge, congestion, and sneezing.
  2. Recurrent infections: Rhinovirus leads to repeated infections, as people are generally susceptible to it. Over one-third of common cold cases are caused by rhinovirus. The rhinovirus family is large, with more than 120 known serotypes, which means immunity is short-lived and reinfections are common.

Parainfluenza Rapid Test Cassette

  Parainfluenza Virus is a respiratory virus that commonly affects children, the elderly, and individuals with weakened immune systems. There are four types (1, 2, 3, and 4), with types 1, 2, and 3 being the most common causes of illnesses like the common cold, croup, and pneumonia.

Key Points:

  • Symptoms: Runny nose, cough, fever, sore throat, and in severe cases, croup or pneumonia.
  • Transmission: Spread through respiratory droplets or contact with contaminated surfaces.
  • Seasonality: More common in fall and spring.
  • Treatment: No specific antiviral treatment; supportive care is usually recommended.
  • Prevention: Good hygiene practices can help reduce spread.

Parainfluenza is a significant cause of respiratory infections, particularly in children, and is typically managed with supportive care.

4o mini 


Mycoplasma pneumoniae Rapid Test Cassette

  Mycoplasma  pneumoniae Rapid Test is a quick diagnostic tool used to detect the presence of Mycoplasma pneumoniae bacteria, one of the leading causes of "walking pneumonia." This test helps healthcare professionals quickly determine whether further diagnosis or treatment is necessary.

Symptoms:

  • Mild Symptoms: Persistent dry cough, sore throat, fever, fatigue, headache.
  • Severe Symptoms: Difficulty breathing, chest pain, severe cough, high fever, and may require hospitalization.

Key Points:

  • Fast and Convenient: Provides rapid results, usually within minutes.
  • Accuracy: Effectively detects Mycoplasma pneumoniae infection, aiding in pneumonia diagnosis.
  • Sample Collection: Typically performed using throat swabs or blood samples.

The rapid test helps quickly and conveniently identify infected individuals, which is crucial for early diagnosis and timely treatment, especially for patients presenting severe symptoms.

4o mini 

Contact Us

Contact Us!

Welcome to visiting here!

 We prioritize our customers and warmly welcome you to visit and share your thoughts during our business hours. 

MEDTEST BIOMEDICAL CO.,LTD

台灣台北市中山區中山北路一段92號8樓之一

Email : info@medtestw.com Tel : +886-2-2522-2291 Adress : 8F-1, No. 92, Sec. 1, Zhongshan N. Rd., Zhongshan Dist., Taipei City 104001, Taiwan (R.O.C.)

今日營業

上午09:00 – 下午05:00

Subscribe

註冊我們的電子報,首次購物即可享九折優惠!

Copyright © 2024 medtestw.com — 保留所有權利。

Powered by GoDaddy

  • TW
  • EN

此網站使用 cookie。

我們會使用 cookie 分析網站流量,並為您最佳化網站的使用體驗。您接受我們使用 cookie,即表示您的資料會和其他使用者的資料進行整合。

接受